Clinical trial / 2010
Oral curcumin-phosphatidylcholine complex was linked to reduced relapse frequency in patients with recurrent anterior uveitis.
This study evaluated adjunctive treatment with Norflo tablets (curcumin-phosphatidylcholine complex; Meriva) given twice daily for 12 months in 106 patients with recurrent anterior uveitis categorized into three etiological groups. The primary endpoint of relapse frequency showed a statistically significant reduction before versus after treatment across all groups (P < 0.001). Additionally, the treatment was well tolerated and reduced eye discomfort signs and symptoms after a few weeks in more than 80% of patients.
- Study type
- Interventional follow-up study
- Who was studied
- 106 patients with recurrent anterior uveitis of different etiologies
- What was measured
- Relapse frequency, relapse severity, and overall quality of life
THE PAPER
Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up.
Allegri P, Mastromarino A, Neri P. Clin Ophthalmol, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.